Total Payments
$35,897
2024 Payments
$13,549
Companies
12
Transactions
100
Medicare Patients
3,193
Medicare Billing
$518,255
Payment Breakdown by Category
Education$14,750 (41.1%)
Other$10,271 (28.6%)
Travel$5,136 (14.3%)
Food & Beverage$2,645 (7.4%)
Consulting$2,525 (7.0%)
Research$570.00 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $14,750 | 4 | 41.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,150 | 4 | 28.3% |
| Travel and Lodging | $5,136 | 34 | 14.3% |
| Food and Beverage | $2,645 | 55 | 7.4% |
| Consulting Fee | $2,525 | 1 | 7.0% |
| Unspecified | $570.00 | 1 | 1.6% |
| Grant | $121.00 | 1 | 0.3% |
Payments by Type
General
$35,327
99 transactions
Research
$570.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $31,338 | 60 | $0 (2024) |
| Janssen Research & Development, LLC | $2,525 | 1 | $0 (2021) |
| AstraZeneca UK Limited | $570.00 | 1 | $0 (2024) |
| GENZYME CORPORATION | $424.86 | 3 | $0 (2019) |
| Photocure Inc | $253.94 | 2 | $0 (2018) |
| Rochester Medical Corporation | $250.93 | 24 | $0 (2022) |
| Astellas Pharma Inc | $140.88 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $122.34 | 3 | $0 (2017) |
| Medtronic USA, Inc. | $121.00 | 1 | $0 (2020) |
| Dendreon Pharmaceuticals LLC | $97.13 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,549 | 23 | INTUITIVE SURGICAL, INC. ($12,811) |
| 2023 | $10,043 | 12 | Intuitive Surgical, Inc. ($10,017) |
| 2022 | $400.93 | 25 | Rochester Medical Corporation ($250.93) |
| 2021 | $9,009 | 7 | Intuitive Surgical, Inc. ($6,484) |
| 2020 | $1,376 | 18 | Intuitive Surgical, Inc. ($1,255) |
| 2019 | $286.63 | 2 | GENZYME CORPORATION ($286.63) |
| 2018 | $277.31 | 2 | Photocure Inc ($139.08) |
| 2017 | $955.17 | 11 | Intuitive Surgical, Inc. ($620.84) |
All Payment Transactions
100 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: SURGERY | ||||||
| 12/27/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
| 12/27/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| Category: SURGERY | ||||||
| 12/11/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $2,750.00 | General |
| Category: SURGERY | ||||||
| 12/05/2024 | AstraZeneca UK Limited | IMFINZI (Biological) | — | Cash or cash equivalent | $570.00 | Research |
| Study: A Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin or Who Refuse Cisplatin Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer • Category: Oncology | ||||||
| 11/08/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $88.90 | General |
| Category: SURGERY | ||||||
| 11/08/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $83.90 | General |
| Category: SURGERY | ||||||
| 11/08/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $74.25 | General |
| Category: SURGERY | ||||||
| 11/05/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $29.85 | General |
| Category: SURGERY | ||||||
| 10/22/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $337.27 | General |
| Category: SURGERY | ||||||
| 10/10/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $297.96 | General |
| Category: SURGERY | ||||||
| 10/10/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $19.00 | General |
| Category: SURGERY | ||||||
| 08/27/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $70.81 | General |
| Category: SURGERY | ||||||
| 07/12/2024 | Becton, Dickinson and Company | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Urology | ||||||
| 07/05/2024 | Becton, Dickinson and Company | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Urology | ||||||
| 05/24/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
| 05/24/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| Category: SURGERY | ||||||
| 05/04/2024 | Astellas Pharma Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $140.88 | General |
| Category: Oncology | ||||||
| 05/03/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $174.11 | General |
| Category: SURGERY | ||||||
| 04/30/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $269.79 | General |
| Category: SURGERY | ||||||
| 04/30/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $263.74 | General |
| Category: SURGERY | ||||||
| 04/30/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $19.00 | General |
| Category: SURGERY | ||||||
| 04/30/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $19.00 | General |
| Category: SURGERY | ||||||
| 10/04/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
| 10/04/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| Category: SURGERY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin or Who Refuse Cisplatin Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer | AstraZeneca UK Limited | $570.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 812 | 5,171 | $914,563 | $107,771 |
| 2022 | 19 | 822 | 3,486 | $1.7M | $158,908 |
| 2021 | 15 | 709 | 2,364 | $849,055 | $103,604 |
| 2020 | 20 | 850 | 2,705 | $1.5M | $147,972 |
Total Patients
3,193
Total Services
13,726
Medicare Billing
$518,255
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2020 | 117 | 174 | $195,750 | $30,376 | 15.5% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2020 | 23 | 23 | $258,658 | $29,060 | 11.2% |
| 50360 | Transplantation of donor kidney | Facility | 2020 | 11 | 11 | $174,405 | $23,109 | 13.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2020 | 11 | 92 | $371,496 | $15,795 | 4.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 162 | 216 | $109,728 | $12,924 | 11.8% |
| 51720 | Bladder instillation of cancer preventive, inhibiting, or suppressive agent | Office | 2020 | 31 | 109 | $65,400 | $8,216 | 12.6% |
| 38571 | Removal of total lymph nodes of both sides of pelvis using an endoscope | Facility | 2020 | 16 | 16 | $70,880 | $4,656 | 6.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 33 | 33 | $35,805 | $4,338 | 12.1% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2020 | 18 | 1,417 | $18,421 | $3,169 | 17.2% |
| 52235 | Destruction and/or removal of (2.0 to 5.0 centimeters) medium growths of the bladder and bladder canal (urethra) using an endoscope | Facility | 2020 | 13 | 13 | $24,895 | $3,127 | 12.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 32 | 34 | $29,172 | $3,064 | 10.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 21 | 21 | $20,160 | $2,599 | 12.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 13 | 13 | $17,680 | $2,202 | 12.5% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 23 | 23 | $19,872 | $2,006 | 10.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2020 | 67 | 91 | $13,670 | $831.15 | 6.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 13 | 15 | $5,310 | $573.46 | 10.8% |
| 81002 | Urinalysis, manual test | Office | 2020 | 84 | 159 | $5,724 | $547.89 | 9.6% |
| 81000 | Manual urinalysis test with examination using microscope | Office | 2020 | 65 | 135 | $4,725 | $526.87 | 11.2% |
| 51741 | Electronic assessment of bladder emptying | Office | 2020 | 32 | 37 | $17,020 | $442.97 | 2.6% |
| 51720 | Bladder instillation of cancer preventive, inhibiting, or suppressive agent | Facility | 2020 | 11 | 12 | $7,200 | $229.40 | 3.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 54 | 61 | $1,525 | $179.35 | 11.8% |
About Arnold Chin, MD, PHD
Arnold Chin, MD, PHD is a Surgical Oncology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2009. The National Provider Identifier (NPI) number assigned to this provider is 1356578066.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Arnold Chin, MD, PHD has received a total of $35,897 in payments from pharmaceutical and medical device companies, with $13,549 received in 2024. These payments were reported across 100 transactions from 12 companies. The most common payment nature is "Education" ($14,750).
As a Medicare-enrolled provider, Chin has provided services to 3,193 Medicare beneficiaries, totaling 13,726 services with total Medicare billing of $518,255. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgical Oncology
- Other Specialties Urology
- Location Los Angeles, CA
- Active Since 06/19/2009
- Last Updated 01/08/2020
- Taxonomy Code 2086X0206X
- Entity Type Individual
- NPI Number 1356578066
Products in Payments
- Da Vinci Surgical System (Device) $31,338
- IMFINZI (Biological) $570.00
- NO PRODUCT DISCUSSED (Drug) $424.86
- Cysview (Drug) $253.94
- Xtandi (Drug) $140.88
- PROVENGE (Drug) $97.13
- Bard Urinary Drainage Bag (Device) $53.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgical Oncology Doctors in Los Angeles
Karim Chamie, M.d, M.D
Surgical Oncology — Payments: $222,147
Surgical Oncology $222,147
Robert Reiter, Md, MD
Surgical Oncology — Payments: $170,624
Surgical Oncology $170,624
Lawrence Menendez, M.d, M.D
Surgical Oncology — Payments: $50,396
Surgical Oncology $50,396
Cristina Ferrone, M.d, M.D
Surgical Oncology — Payments: $35,968
Surgical Oncology $35,968
Dr. John Kang, M.d, M.D
Surgical Oncology — Payments: $33,340
Surgical Oncology $33,340
James Economou, Md, MD
Surgical Oncology — Payments: $26,550
Surgical Oncology $26,550